Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by 1ottrunneron May 05, 2021 7:50am
105 Views
Post# 33130493

RE:RE:RE:RE:Trial update

RE:RE:RE:RE:Trial update

Term, every single trial in the world costs millions and about half fail Phase 3.

Oncyolitic trials are just 15% successful and Billions are spent exploring new therapies.

They do not KNOW bucillamine is a winner.  They think the method of action will prove successful and it looks great, but Bill Gates thought the same of Colchicine, whihc had the same method of action (less potent in a clinical setting-->which is potentially good for RVV).

I'm long on this just like the rest of us.  What would be great is if we could have a dialog rather than burying this thread in stupid breaking news that either has nothing to do with RVV or is littered with BS DD.

I feel terrible for some of the folks that have put every egg in this basket, there is still a chance the trial will fail, or worse, be successful too late!


TheTerminator1 wrote: We will all be celebrating soon Big Guy

RVV would not be spending Millions and Millions for nothing,yjey know Bucillamine is a winner....

Keep in mind that Bucillamine will also be used for other nasty viruses :)

Long and strong 
 

1ottrunner wrote: I expect the trial is very close or has passed 400 participants.

Just 22 patients per site would get it to 1000 patients.

60 days tops.




<< Previous
Bullboard Posts
Next >>